美国週边神经损伤市场规模、份额、趋势分析报告：按产品/疗法、按程序、按应用、按最终用途、按地区、按细分市场预测，2025-2030 年

美国週边神经损伤市场的成长和趋势

根据Grand View Research, Inc.最新报告，预计到2030年，美国週边神经损伤市场规模将达到7.125亿美元，2025年至2030年复合年增长率为7.4%。该市场的成长归因于美国医疗保健支出的增加、週边神经损伤盛行率的增加、对研发的日益关注以及患者对微创手术的偏好增加。

技术进步正在彻底改变美国的周边神经损伤治疗领域。神经移植、神经导管和神经刺激设备等新型创新治疗方案正在帮助改善治疗结果并加速患者復原。此外，微创手术技术的使用，如终末神经缝合和神经减压手术，由于具有更快恢復的优点而在患者中越来越受欢迎。医疗技术的这些进步透过提供更有效、侵入性更小的治疗方法正在推动市场成长。

主要市场参与企业的投资以及学术界、工业界和医疗机构之间的合作正在推动研发工作，从而发现新的治疗方法。例如，2022 年 6 月，再生医学领域领先的生物技术公司 Vascudyne, Inc.津贴，用于一项名为「使用再生工程组织管生产周围神经包裹」的研究。该研究将从 2022 年 6 月开始资助一年，资助金额为 10 万美元，并将利用 Bascudine 的 TRUE Tissue 技术。

COVID-19 大流行正在推动对微创手术的需求，因为它具有更快的恢復时间、可能更低的成本、更好的治疗选择以及与远端医疗技术整合等优点。这些因素可能会对美国週边神经损伤市场产生正面影响。

美国週边神经损伤市场报告亮点

• 从产品/疗法来看，由于自体移植、同种异体移植和合成导管等神经移植技术的快速发展，神经移植领域将在 2024 年占据美国週边神经损伤市场占有率65.1% 的份额。
• 透过手术，直接神经修復占据了美国週边神经损伤市场的主导地位，占据了最大的销售份额，约42.5%。它被认为是重症病例手术治疗的黄金标准。
• 从应用来看，2024年上肢部分在美国週边神经损伤市场占有率中所占比重最大，占81.2%。意外跌倒和Guillain-Barré二氏症候群、糖尿病和腕管综合症等疾病的发病率正在上升，预计将推动这一细分市场的发展。
• 按最终用途划分，医院细分市场将在 2024 年占据主导地位。医院数量的增加和医院手术病例的增加预计将推动这一领域的发展。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国週边神经损伤市场变数、趋势、范围

• 市场体系展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 营商环境分析
  • 产业分析-波特五力分析
  • PESTLE分析

第四章美国週边神经损伤市场：产品/疗法业务分析

• 2024 年及 2030 年产品/疗法市场占有率
• 产品/治疗细分仪表板
• 2018-2030 年按产品/疗法分類的市场规模、预测和趋势分析
• 神经移植
• 生物材料

第五章美国週边神经损伤市场：手术业务分析

• 2024年及2030年手术市场占有率
• 手术细分仪表板
• 2018-2030 年按手术分類的市场规模、预测与趋势分析
• 直接神经修復
• 神经移植
• 干细胞疗法
• 内神经松解术
• 神经缝合

第六章美国週边神经损伤市场：应用业务分析

• 2024年及2030年应用市场占有率
• 使用细分仪表板
• 2018-2030 年市场规模、预测与趋势分析（按应用）
• 上肢
• 下肢

第七章美国週边神经损伤市场：最终用途业务分析

• 2024 年及 2030 年最终用途市场占有率
• 最终用途细分仪表板
• 2018-2030 年按最终用途分類的市场规模、预测与趋势分析
• 医院
• 诊所
• 门诊手术中心
• 其他的

第八章 竞争格局

• 参与者概览
• 公司市场分析
• 公司分类
• 策略规划
• 公司简介/上市公司
  • Axogen Corporation
  • Stryker
  • Regenity
  • Integra LifeSciences Corporation
  • TOYOBO CO., LTD.
  • Alafair Biosciences, Inc.
  • SYNOVIS MICRO COMPANIES ALLIANCE, INC.,（BAXTER INTERNATIONAL INC.）

U.S. Peripheral Nerve Injuries Market Growth & Trends:

The U.S. peripheral nerve injuries market size is estimated to reach USD 712.5 million by 2030, registering a CAGR of 7.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is due to increasing healthcare expenditure in the U.S., an increasing prevalence of peripheral nerve injuries, growing focus on research and development, and a growing patient preference for minimally invasive procedures.

Technological advancements are revolutionizing the field of peripheral nerve injury treatment in the U.S. New and innovative treatment options such as nerve grafts, nerve conduits, and neurostimulation devices are providing improved outcomes and helping patients recover faster. Additionally, the use of minimally invasive surgical techniques, such as end-to-end nerve sutures and nerve decompression procedures, is gaining popularity among patients due to their benefits of faster recovery times. These advancements in medical technology are driving the growth of the market by providing more effective and less invasive treatment options.

Investments from key market players and collaborations between academia, industry, and healthcare institutions are driving R&D efforts, leading to the discovery of new treatment modalities. For instance, in June 2022, Vascudyne, Inc., a leading biotechnology company in regenerative medicine, was awarded a grant from Regenerative Medicine Minnesota for a research study titled "Production of a Peripheral Nerve Wrap Using Tissue Tubes from Regenerative Engineering." The study will be funded with USD 100,000 for one year, starting in June 2022, and will utilize Vascudyne's TRUE Tissue technology.

The COVID-19 pandemic has boosted the demand for minimally invasive procedures as it offer benefits such as shorter recovery times, potentially lower costs, better treatment options, and integration with telemedicine technologies. These factors may impact the market for U.S. peripheral nerve injuries positively.

U.S. Peripheral Nerve Injuries Market Report Highlights:

• Based on product/therapies, Nerve grafting segment dominated the U.S. peripheral nerve injury market share in 2024, accounting for 65.1%, owing to rapid advancements in nerve grafting techniques, such as autografts, allografts, and synthetic conduits
• Based on surgery, direct nerve repair segment dominated the U.S. peripheral nerve injury market and held the largest revenue share of nearly 42.5%. It is considered the gold standard of surgical treatment for severe cases
• Based on application, upper extremities segment held the largest U.S. peripheral nerve injury market share in 2024, accounting for 81.2%. increasing incidence of accidental falls and medical conditions, such as Guillain-Barre syndrome, diabetes, & carpal tunnel syndrome, is expected to drive the segment
• Based on end use, hospitals segment dominated the market in 2024. Increasing number of hospitals and surgical cases in hospitals are expected to boost the segment.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Products/Therapies
  • 1.2.2. Surgery
  • 1.2.3. Application
  • 1.2.4. End use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Peripheral Nerve Injury Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Business Environment Analysis
  • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Peripheral Nerve Injury Market: Products/Therapies Business Analysis

• 4.1. Products/Therapies Market Share, 2024 & 2030
• 4.2. Products/Therapies Segment Dashboard
• 4.3. Market Size & Forecasts and Trend Analysis, by Products/Therapies, 2018 to 2030 (USD Million)
• 4.4. Nerve Grafting
  • 4.4.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
  • 4.4.2. Autograft
    • 4.4.2.1. Autograft Market, 2018 - 2030 (USD Million)
  • 4.4.3. Allograft
    • 4.4.3.1. Allograft Market, 2018 - 2030 (USD Million)
  • 4.4.4. Stem Cell Therapy
    • 4.4.4.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
• 4.5. Biomaterial
  • 4.5.1. Biomaterial Market, 2018 - 2030 (USD Million)
  • 4.5.2. Nerve Conduit
    • 4.5.2.1. Nerve Conduit Market, 2018 - 2030 (USD Million)
  • 4.5.3. Nerve Protector
    • 4.5.3.1. Nerve Protector Market, 2018 - 2030 (USD Million)
  • 4.5.4. Nerve Connector
    • 4.5.4.1. Nerve Connector Market, 2018 - 2030 (USD Million)
  • 4.5.5. Nerve Wraps
    • 4.5.5.1. Nerve Wraps Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Peripheral Nerve Injury Market: Surgery Business Analysis

• 5.1. Surgery Market Share, 2024 & 2030
• 5.2. Surgery Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analysis, by Surgery, 2018 to 2030 (USD Million)
• 5.4. Direct Nerve Repair
  • 5.4.1. Direct Nerve Repair Market, 2018 - 2030 (USD Million)
• 5.5. Nerve Grafting
  • 5.5.1. Nerve Grafting Market, 2018 - 2030 (USD Million)
• 5.6. Stem Cell Therapy
  • 5.6.1. Stem Cell Therapy Market, 2018 - 2030 (USD Million)
• 5.7. Internal Neurolysis
  • 5.7.1. Internal Neurolysis Market, 2018 - 2030 (USD Million)
• 5.8. Neurorrhaphy
  • 5.8.1. Neurorrhaphy Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Peripheral Nerve Injury Market: Application Business Analysis

• 6.1. Application Market Share, 2024 & 2030
• 6.2. Application Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Upper Extremities
  • 6.4.1. Upper Extremities Market, 2018 - 2030 (USD Million)
• 6.5. Lower Extremities
  • 6.5.1. Lower Extremities Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Peripheral Nerve Injury Market: End Use Business Analysis

• 7.1. End Use Market Share, 2024 & 2030
• 7.2. End Use Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Hospitals
  • 7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
• 7.5. Clinics
  • 7.5.1. Clinics Market, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Participant Overview
• 8.2. Company Market Position Analysis
• 8.3. Company Categorization
• 8.4. Strategy Mapping
• 8.5. Company Profiles/Listing
  • 8.5.1. Axogen Corporation.
    • 8.5.1.1. Overview
    • 8.5.1.2. Financial Performance
    • 8.5.1.3. Product Benchmarking
    • 8.5.1.4. Strategic Initiatives
  • 8.5.2. Stryker
    • 8.5.2.1. Overview
    • 8.5.2.2. Financial Performance
    • 8.5.2.3. Product Benchmarking
    • 8.5.2.4. Strategic Initiatives
  • 8.5.3. Regenity
    • 8.5.3.1. Overview
    • 8.5.3.2. Financial Performance
    • 8.5.3.3. Product Benchmarking
    • 8.5.3.4. Strategic Initiatives
  • 8.5.4. Integra LifeSciences Corporation.
    • 8.5.4.1. Overview
    • 8.5.4.2. Financial Performance
    • 8.5.4.3. Product Benchmarking
    • 8.5.4.4. Strategic Initiatives
  • 8.5.5. TOYOBO CO., LTD.
    • 8.5.5.1. Overview
    • 8.5.5.2. Financial Performance
    • 8.5.5.3. Product Benchmarking
    • 8.5.5.4. Strategic Initiatives
  • 8.5.6. Alafair Biosciences, Inc.
    • 8.5.6.1. Overview
    • 8.5.6.2. Financial Performance
    • 8.5.6.3. Product Benchmarking
    • 8.5.6.4. Strategic Initiatives
  • 8.5.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC., (BAXTER INTERNATIONAL INC.)
    • 8.5.7.1. Overview
    • 8.5.7.2. Financial Performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic Initiatives

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviations
• Table 3. U.S. peripheral nerve injury market, by product/therapies, 2018 - 2030 (USD Million)
• Table 4. U.S. peripheral nerve injury market, by surgery, 2018 - 2030 (USD Million)
• Table 5. U.S. peripheral nerve injury market, by application, 2018 - 2030 (USD Million)
• Table 6. U.S. peripheral nerve injury market, end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 U.S. peripheral nerve injury market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Market formulation & validation
• Fig. 7 Market snapshot
• Fig. 8 Segment outlook
• Fig. 9 Competitive landscape
• Fig. 10 U.S. peripheral nerve injury market dynamics
• Fig. 11 U.S. peripheral nerve injury market: Porter's five forces analysis
• Fig. 12 U.S. peripheral nerve injury market: PESTLE analysis
• Fig. 13 U.S. peripheral nerve injury market: Products/therapies segment dashboard
• Fig. 14 U.S. peripheral nerve injury market: Products/therapies market share analysis, 2024 & 2030
• Fig. 15 Nerve grafting market, 2018 - 2030 (USD Million)
• Fig. 16 Autograft market, 2018 - 2030 (USD Million)
• Fig. 17 Allograft market, 2018 - 2030 (USD Million)
• Fig. 18 Stem cell therapy market, 2018 - 2030 (USD Million)
• Fig. 19 Biomaterial market, 2018 - 2030 (USD Million)
• Fig. 20 Nerve conduit market, 2018 - 2030 (USD Million)
• Fig. 21 Nerve protector market, 2018 - 2030 (USD Million)
• Fig. 22 Nerve connector market, 2018 - 2030 (USD Million)
• Fig. 23 U.S. peripheral nerve injury market: Surgery segment dashboard
• Fig. 24 U.S. peripheral nerve injury market: Surgery market share analysis, 2024 & 2030
• Fig. 25 Direct nerve repair market, 2018 - 2030 (USD Million)
• Fig. 26 Nerve grafting market, 2018 - 2030 (USD Million)
• Fig. 27 Stem cell therapy market, 2018 - 2030 (USD Million)
• Fig. 28 Carpal tunnel release market, 2018 - 2030 (USD Million)
• Fig. 29 Internal neurolysis market, 2018 - 2030 (USD Million)
• Fig. 30 Neurorrhaphy market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. peripheral nerve injury market: Application segment dashboard
• Fig. 32 U.S. peripheral nerve injury market: Application market share analysis, 2024 & 2030
• Fig. 33 Upper extremities market, 2018 - 2030 (USD Million)
• Fig. 34 Lower extremities market, 2018 - 2030 (USD Million)
• Fig. 35 U.S. peripheral nerve injury market: End use segment dashboard
• Fig. 36 U.S. peripheral nerve injury market: End use market share analysis, 2024 & 2030
• Fig. 37 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 38 Clinics market, 2018 - 2030 (USD Million)
• Fig. 39 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
• Fig. 40 Others market, 2018 - 2030 (USD Million)
• Fig. 41 Company categorization
• Fig. 42 Company market position analysis
• Fig. 43 Strategic framework